Research interests
Non-invasive prenatal diagnosis
Red cell biology
UoP Research Group Membership
Centre for Research in Translational Biomedicine
Publications
2011
Madgett T.E., Pearl M., Jones J.W., Scott M.L. & Avent N.D.
Molecular characterisation of the partial RhD variants DHMi and DHMii
Submitted to Transfusion, May 2011
2009
Jeremy K.P., Plummer Z.E., Head D.J., Madgett T.E., Sanders K.L., Wallington A., Storry J.R., Gilsanz F., Delaunay J. & Avent N.D. [Times cited 2]
4.1R-deficient human red blood cells have altered phosphatidylserine exposure pathways and are deficient in CD44 and CD47 glycoproteins
Haematologica
(2009) 94 (10) 1354-1361
Maddocks D.G., Alberry M.S., Attilakos G., Madgett T.E., Choi K., Soothill P.W. & Avent N.D. [Times cited 6]
The SAFE project: towards non-invasive prenatal diagnosis
Biochemical Society Transactions (2009) 37 (Pt 2) 460-465
Avent N.D., Madgett T.E., Maddocks D.G. & Soothill P.W. [Times cited 3]
Cell-free fetal DNA in the maternal serum and plasma: current and evolving applications
Current Opinion in Obstetrics and Gynecology (2009) 21 (2) 175-179
Avent N.D., Martinez A., Flegel W.A., Olsson M.L., Scott M.L., Nogues N., Pisacka M., Daniels G.L., Muniz-Diaz E., Madgett T.E., Storry J.R., Beiboer S., Maaskant-van Wijk P.M., von Zabern I., Jimenez E., Tejedor D., Lopez M., Camacho E., Cheroutre G., Hacker A., Jinoch P., Svobodova I., van der Schoot E., de Haas M. [Times cited 2]
The Bloodgen Project of the European Union, 2003-2009
Transfusion Medicine and Hemotherapy (2009) 36 (3) 162-167
2008
Avent N.D., Plummer Z.E., Madgett T.E., Maddocks D.G. & Soothill P.W. [Times cited 9]
Post-genomics studies and their application to non-invasive prenatal diagnosis
Seminars in Fetal & Neonatal Medicine (2008) 13 (2) 91-98
2007
Avent N.D., Martinez A., Flegel W.A., Olsson M.L., Scott M.L., Nogués N., Písačka M., Daniels G.L., van der Schoot E., Muñiz-Diaz E., Madgett T.E., Storry J.R., Beiboer S.H., Maaskant-van Wijk P.A., von Zabern I., Jiménez E., Tejedor D., López M., Camacho E., Cheroutre G., Hacker A., Jinoch P., Svobodova I. & de Haas M. [Times cited 33]
The Bloodgen Project : Toward Mass Scale Comprehensive Genotyping of Blood Donors in the European Union and beyond.
Transfusion (2007) 47 (1 Suppl) 40S-46S
2006
Avent N.D., Madgett T.E., Lee Z.E., Head D.J., Maddocks D.G. & Skinner L.H.
The Rh Blood Group system: Molecular biology and applications in molecular medicine.
Expert Reviews in Molecular Medicine (2006) 8 (13) 1-20
(Maiden surname Crew)
2005
Fox B.C., Crew T.E. & Welham M.J. [Times cited 5]
Phosphoinositide 3-kinases can act independently of p27Kip1 to regulate optimal IL-3-dependent cell cycle progression and proliferation.
Cellular Signalling (2005) 17 (4) 473-487
2003
Charalambous M., Smith F.M., Bennett W.R., Crew T.E., Mackenzie F. & Ward A. [Times cited 98]
Disruption of the imprinted Grb10 gene leads to disproportionate overgrowth by an Igf2-independent mechanism.
Proceedings of the National Academy of Sciences of the United States of America (2003) 100 (14) 8292-8297
Bennett W.R., Crew T.E., Slack J.M.W. & Ward A. [Times cited 22]
Structural-proliferative units and organ growth: Effects of insulin-like growth factor 2 on the growth of colon and skin.
Development (2003) 130 (6) 1079-1088
2000
Elder D.J.E., Halton D.E., Crew T.E. & Paraskeva C. [Times cited 76]
Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398.
International Journal of Cancer (2000) 86 (4) 553-560
Crew T.E., Elder D.J.E. & Paraskeva C. [Times cited 58]
A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: Regulation of COX-2 by butyrate.
Carcinogenesis (2000) 21 (1) 69-77
